Off topic [Regulatives / Guidelines]

posted by ElMaestro  – Denmark, 2015-07-03 15:02 (4013 d 03:25 ago) – Posting: # 15034
Views: 10,034

Hi all,

I am still baffled by scaling, whichever way it is done. Granted, I do not understand much of BE and in particular I am struggling with scaling. I am baffled for this reason:

As an alternative to scaling we might in stead relax the alpha and keep accepting and rejecting the same products. We would achieve not just roughly the same but exactly the same because scaling keeps the GMR unaffected. A practical matter is of course to identify the mathematical relationship between the scaling constant of acceptance range and scaling of alpha but this is nothing more than a practicality (find a closed form or chose empery, whatever works for you).

I think the only reason not to formulate the problem (=acceptance vs rejection) in terms of alpha relaxation but rather in terms of widening of CI limits is that if we formulate it as a widening of alpha level then we need to admit explicitly what scaling involves: An occasional increase in type I error.

Prove me wrong, please.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
336 visitors (0 registered, 336 guests [including 14 identified bots]).
Forum time: 18:27 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5